Comparison	O
with	O
alkaline	B
phosphatases	I
and	O
5-nucleotidase	B
Pharmacologic	O
aspects	O
of	O
neonatal	O
hyperbilirubinemia	O
.	O
When	O
CSF	O
-LSB-	O
HCO3	O
-	O
-RSB-	O
is	O
shown	O
as	O
a	O
function	O
of	O
CSF	O
PCO2	O
the	O
data	O
of	O
K-depleted	O
rats	O
are	O
no	O
longer	O
Intravenous	O
administration	O
-LRB-	O
25	O
mg/kg	O
-RRB-	O
of	O
carbonic	B
anhydrase	I
inhibitors	O
-LRB-	O
acetazolamide	O
,	O
methazolamide	O
,	O
dichlorphenamide	O
,	O
sulthiame	O
-RRB-	O
induced	O
an	O
early	O
important	O
rise	O
of	O
cortical	O
p	O
O2	O
,	O
which	O
is	O
not	O
dependent	O
on	O
increase	O
of	O
p	O
O2	O
and	O
p	O
CO2	O
and	O
decrease	O
of	O
pH	O
in	O
arterial	O
blood	O
.	O
Takayasu	O
's	O
disease	O
:	O
association	O
with	O
HLA-B5	B
.	O
